Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
|
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 305 044 983 | 61 479 792 ( 20,15 %) | 2 654 717 ( 0,8703 %) | 20,15 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
ALCON INC. 1,29% | 6 438 707 | 1,29% | 573 881 955 $ |
Unternehmenskontakt
![Straße Alcon, Inc.(ACL)](https://cdn.zonebourse.com/static/address/11520.png)
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Alcon Pharmaceuticals Ltd.
![]() Alcon Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Alcon Pharmaceuticals Ltd. supplies pharmaceuticals products. The company is headquartered in Fribourg, Switzerland. |
Medical Specialties
|
Alcon Laboratories (India) Pvt Ltd.
![]() Alcon Laboratories (India) Pvt Ltd. Medical DistributorsDistribution Services Alcon Laboratories (India) Pvt Ltd. provides pharmaceutical products and services. The company is headquartered in Bangalore, India. |
Medical Distributors
|
Alcon Singapore Manufacturing Pte Ltd.
![]() Alcon Singapore Manufacturing Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of Alcon AG, Alcon Singapore Manufacturing Pte Ltd. is a company that engages in chemical preparations. The company is based in Singapore, Singapore. |
Pharmaceuticals: Major
|
Alcon Management SA
| |
Alcon Finance Corp.
![]() Alcon Finance Corp. Finance/Rental/LeasingFinance Alcon Finance Corp.provides financing services. The company is headquartered in Delaware, United States. |
Finance/Rental/Leasing
|
Alcon Laboratories Belgium BVBA
![]() Alcon Laboratories Belgium BVBA Pharmaceuticals: MajorHealth Technology Part of Alcon AG, Alcon Laboratories Belgium BV is a Belgian company that manufactures medicines. The company is located in Belgium. |
Pharmaceuticals: Major
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+22,00 % | 44,71 Mrd. | |
-5,71 % | 17,88 Mrd. | |
-30,03 % | 1,95 Mrd. | |
+11,49 % | 1,85 Mrd. | |
+22,32 % | 1,17 Mrd. | |
+70,82 % | 661 Mio. | |
-12,09 % | 637 Mio. | |
-44,49 % | 629 Mio. | |
-48,16 % | 600 Mio. |